Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
Clinical trial NCT05080764 · COMPLETED
Trial details
- NCT number
- NCT05080764
- Sponsor
- Biofrontera Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2025-08-22
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.